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Propolis contains high concentrations of polyphenols, flavonoids, tannins, ascorbic acid, and reducing sugars and proteins.
Malaysian Propolis (MP) has been reported to exhibit high 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity and
ferric reducing antioxidant power (FRAP) values. Herein, we report the antioxidant properties and cardioprotective properties of
MP in isoproterenol- (ISO-) inducedmyocardial infarction in rats. MaleWistar rats (𝑛 = 32) were pretreated orally with an ethanol
extract ofMP (100mg/kg/day) for 30 consecutive days. Subcutaneous injection of ISO (85mg/kg in saline) for two consecutive days
caused a significant increase in serum cardiac marker enzymes and cardiac troponin I levels and altered serum lipid profiles. In
addition significantly increased lipid peroxides and decreased activities of cellular antioxidant defense enzymeswere observed in the
myocardium. However, pretreatment of ischemic rats with MP ameliorated the biochemical parameters, indicating the protective
effect of MP against ISO-induced ischemia in rats. Histopathological findings obtained for the myocardium further confirmed the
biochemical findings. It is concluded that MP exhibits cardioprotective activity against ISO-induced oxidative stress through its
direct cytotoxic radical-scavenging activities. It is also plausible that MP contributed to endogenous antioxidant enzyme activity
via inhibition of lipid peroxidation.
1. Introduction
Propolis, or bee glue, is a resinous product collected by bees
from various plant sources, such as buds and exudates. The
substance is sticky at and above room temperature (20∘C),
but at lower temperature it becomes hard and brittle [1–3].
Propolis is used as a sealant by bees to seal cracks in hives,
encapsulate invader carcasses, repair combs, and strengthen
thin borders [1, 2, 4]. Depending on its source, geographical
climate, and age, propolis varies greatly; it possesses a
pleasant aromatic odor and occurs in different colors, such
as yellow, cream, green, and light or dark brown [5].
Propolis is mainly composed of resins, polyphenols,
flavonoids, fatty acids, essential oils, wax, pollen, and other
organics andminerals. Propolis contains at least 38 flavonoids
[6]. It also contains vitamin B complexes; vitamins C and E;
important minerals such as Zn, Mg, Cu, Fe, Mn, Ni, and Ca;
and some trace elements [7]. Due to the presence of com-
pounds such as flavonoids, phenolic acids, and their esters,
propolis exhibits anti-inflammatory, antibacterial, antiviral,
immunomodulatory, antioxidant, and antiproliferative prop-
erties [8]. Reactive oxygen species (ROS) such as superoxide
anions and hydroxyl radicals are scavenged by antioxidants
present in propolis [9, 10]. In addition, the extreme reactivity
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of ROS toward lipids and proteins contributes to their rapid
damaging capacity [11].
Myocardial infarction (MI), commonly known as “heart
attack,” occurs due to an interruption in the supply of blood
to heart tissue. As a result of coronary artery occlusion,
necrosis of part of the myocardium occurs [12]. In fact,
an imbalance between coronary blood supply and myocar-
dial demand is the main cause of myocardium necrosis
resulting from MI [13]. MI is a common presentation of
ischemic heart disease (IHD) and is followed by numerous
pathophysiological and biochemical changes, including lipid
peroxidation (LPO), hyperglycemia, and hyperlipidemia [14].
In the developed world and most developing countries, MI is
one of the main causes of mortality and morbidity [12, 15].
At low concentration, catecholamines exert a positive
ionotropic effect and are beneficial in regulating heart
function.However, when present in high doses (administered
or released in excess from the endogenous stores), catechol-
amines can deplete the reserved energy of cardiomyocytes,
resulting in structural and biochemical changes leading to
irreversible damage. Isoproterenol 4-[1-hydroxy-2-(isopro-
pylamino)ethyl] benzene-1,2-diol hydrochloride (ISO) is a
synthetic catecholamine and𝛽-adrenergic agonist that causes
severe stress to the myocardium, resulting in an infarct-
like necrosis of the heart muscle [16]. Free radicals thus
produced may attack polyunsaturated fatty acids (PUFAs)
within membranes, forming peroxyl radicals. These radicals
then attack adjacent fatty acids, causing a chain reaction of
LPO. Lipid hydroperoxide end products are harmful and
may be responsible for the disruption of the integrity of the
myocardial membrane [17, 18].
Recently, a number of Malaysian agro-food-based re-
search institutes and local beekeepers have collected the bee
propolis of different species to analyze its composition as
well as its health benefits [19, 20]. Propolis from the Trigona
itama species of Malaysia has been reported to contain a
number of bioactive compounds with biological activities.
Themajor phytochemicals identified inMP are hexadecanoic
acid, which acts as an antioxidant; phenylethyl alcohol and
dodecanoic acid, which act as antimicrobial agents; and
norolean-12-ene, ethyl octadecanoate, 8-octadecanoic acid,
and 9-octadecanoic acid, which serve as anti-inflammatory
agents [19]. A previous study demonstrated that propolis con-
tains remarkable antioxidant properties, mainly attributed to
its phenolic and flavonoid contents [21].The aim of this study
was to investigate the antioxidant properties of Malaysian
Propolis (MP) and its cardioprotective effect, elucidating the
mechanism that occurs in ISO-induced MI in rats.
2. Materials and Methods
2.1. Chemicals and Drugs. Gallic acid, catechin, 1,1-diphenyl-
2-picrylhydrazyl (DPPH) radical, and 2,4,6-tris(2-pyridyl)-
1,3,5-triazine (TPTZ) standards were purchased from
Sigma-Aldrich (St. Louis, MO). Tannic acid, L-ascorbic
acid, and Folin-Ciocalteu’s phenol reagent were purchased
from Merck Co. (Darmstadt, Germany). ISO and 1,1,3,3-
tetraethoxypropane were purchased from Nacalai Tesque,
Inc. Kyoto, Japan. All chemicals and reagents used in this
study were of analytical grade.
2.2. Propolis Sample. Stingless bee propolis of Tetratrigona
subgenus (genus: Trigona) was collected from theMin House
Camp, Kubang Kerian, Kelantan, Malaysia in June 2013.
2.3. Extract Preparation. Propolis extract (20%)was prepared
according to the method described by Laskar et al. [22]. Solid
propolis samples (200 g) were first cut into small pieces using
a sterile, smooth steel knife. The samples were soaked with
ethanol (70%) for 48 hours and then shaken (150 rpm) at 30∘C
for 72 hours. The extract solution was filtered withWhatman
number 1 filter paper and dried in a rotary evaporator
(Buchi, Tokyo, Japan) under a reduced pressure (100 psi) and
at a controlled temperature (40∘C). The dried extract was
collected and finally preserved at −20∘C for subsequent in
vitro and in vivo studies.
2.4. Phytochemical Analysis
2.5. Estimation of Total Polyphenols. The total polyphenol
content of the propolis extract was estimated by spectromet-
ric determination based on Folin-Ciocalteu’s method [23]
using a PD-303S spectrophotometer (APEL, Japan). Briefly,
0.4mL of sample extract (10mg/mL) was mixed with 1.6mL
of 7.5% sodium carbonate solution. Then, 2mL of 10-fold
diluted Folin-Ciocalteu’s reagent was added, and the final
reaction mixture was incubated for 1 hour in the dark. Total
polyphenol content was determined as gallic acid equivalent
(GAE) (6.25–100.00 𝜇g/mL) and expressed as mg of GAEs/g
of propolis. The color intensity of the blue complex was
measured at 765 nm.
2.6. Estimation of Total Flavonoids. The total flavonoid con-
tent was estimated using an aluminum chloride colorimetric
assay [24]. First, 1mL of sample (10mg/mL) was mixed
with 0.3mL of 5% sodium nitrite and added to the reaction
mixture; after approximately 5min, 0.3mL of 10% aluminum
chloride was added. Subsequently, another 2mL of 1M
sodium hydroxide (NaOH) was added after 6min, followed
by the immediate addition of 2.4mL of distilled water to
produce a total volume of 10mL. The color intensity of the
flavonoid-aluminum complex was measured at 510 nm. Total
flavonoid content was determined as catechin equivalent
(CE) (6.25–100.00 𝜇g/mL) and expressed as mg of CEs/g of
propolis.
2.7. Determination of Ascorbic Acid Content. The ascorbic
acid content in the propolis was estimated by a method
established by Omaye et al. [25], with slight modifica-
tions. Briefly, 1mL of extract (10mg/mL) was mixed with
1mL of a 5% trichloroacetic acid (TCA) solution and
centrifuged for 15min at 3500 rpm. Then, 0.5mL of the
supernatant was mixed with 0.1mL of DTC (2,4-dinitro-
phenylhydrazine/thiourea/copper) solution and incubated
for 3 hours at 37∘C. To the mixture was added 0.75mL of ice-
cold 65% H2SO4. The solution was allowed to stand for an
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additional 30min at room temperature.The colored complex
that developed was monitored at 520 nm. The ascorbic acid
concentration was determined as ascorbate equivalent (AEs)
(1–10 𝜇g/mL) and expressed as mg of ascorbate equivalents
(AEs) per g of sample.
2.8. Estimation of Reducing Sugar Content. The content of
reducing sugars in the propolis was estimated according to
the Nelson-Somogyi method [26]. Briefly, 2mL of propolis
extract (10 𝜇g/mL) and standards (made in 0.2% of benzoic
acid) were transferred into two different test tubes, followed
by the addition of 2mL of copper reagent to each tube.
The tubes were heated for 15min in a 100∘C water bath and
then cooled. Finally, 1mL of arsenomolybdate color reagent
was added to the reaction mixture. The absorbance was
measured at 520 nm. Dextrose was used as a standard for the
preparation of the calibration curve (10–100 𝜇g/mL), and the
reducing sugar content was expressed as mg of D-glucose per
g of propolis.
2.9. Estimation of Total Protein Content. The total protein
content in the propolis was estimated using Lowry’s method
[27]. Bovine serum albumin (BSA) (12.5–100.0 𝜇g/mL) was
used as a standard to prepare a calibration curve. The final
results are expressed as mg of BSA equivalent per g of
propolis.
2.10. Analysis of Antioxidant Properties. To investigate the
antioxidant potential of the propolis extracts, DPPH radical-
scavenging and FRAP assays were performed.
2.11. DPPH Free Radical-Scavenging Activity. The antioxidant
potential of the propolis was determined according to the
DPPH radical-scavenging activity based on a method estab-
lished by Braca et al. [28]. Briefly, 1mL of the extract was
mixed with 1.2mL of 0.003% DPPH in methanol at varying
concentrations (2.5–80.0 𝜇g/mL). The percentage of DPPH
inhibition was calculated using the following equation:
% of DPPH inhibition = [(𝐴DPPH − 𝐴𝑆𝐴DPPH )] × 100, (1)
where 𝐴DPPH is the absorbance of DPPH in the absence of a
sample and 𝐴𝑆 is the absorbance of DPPH in the presence of
either the sample or the standard.
DPPH scavenging activity is expressed as the concentra-
tion of sample that is required to decrease DPPH absorbance
by 50% (IC50). The value can be graphically determined
by plotting the absorbance (the percentage of inhibition of
DPPH radicals) against the log concentration of DPPH and
determining the slope of the nonlinear regression.
2.12. Ferric Reducing Antioxidant Power (FRAP) Assay. The
FRAP assay was performed according to a method estab-
lished by Benzie and Strain [29]. The reduction of a ferric
tripyridyltriazine complex into its ferrous form produces
an intense blue color at low pH that can be monitored
by measuring absorbance at 593 nm. Briefly, 200𝜇L of the
solution at different concentrations (62.5–1000.0𝜇g/mL) was
mixed with 1.5mL of the FRAP reagent, and the reaction
mixture was incubated at 37∘C for 4min. The change in
absorbance was monitored at 593 nm against a distilled water
blank.The FRAP reagent was prepared by mixing 10 volumes
of 300mM acetate buffer (pH 3.6) with 1 volume of 10mM
TPTZ solution in 40mM hydrochloric acid and 1 volume
of 20mM ferric chloride (FeCl3⋅6H2O). The FRAP reagent
was prewarmed to 37∘C and was always freshly prepared.
A standard curve was plotted using an aqueous solution of
ferrous sulfate (FeSO4⋅7H2O) (100–1000𝜇mol), with FRAP
values expressed as micromoles of ferrous equivalent (𝜇M Fe
[II] per kg of sample).
2.13. Experimental Animals. Adult male Wistar Albino rats
ranging from 140 to 160 g were used.The animals were main-
tained under standard conditions of ventilation, temperature
(23 ± 2∘C), humidity (40–70%), and light/dark condition
(12/12 h) in the animal house facility of the Department of
Biochemistry and Molecular Biology, Jahangirnagar Univer-
sity, Savar, Dhaka. The rats were housed in polypropylene
cages with soft wood-chip bedding.They were provided with
a standard laboratory pellet diet and water ad libitum. The
experiments were conducted according to the ethical guide-
lines as approved by Bangladesh Association for Laboratory
Animal Science. The experiment protocol was approved by
theBiosafety, Biosecurity, andEthical Committee of Jahangir-
nagar University [Approval number BBEC, JU/M2014 (3)].
2.14. Induction of Experimental MI. MI was induced by
subcutaneous injection of ISO (85mg/kg). ISO was dissolved
in normal saline and administered twice at an interval of
24 h for two consecutive days. The ISO dose was established
based on a pilot study for ISO dose fixation and the results of
previous studies [12, 18]. Animals were sacrificed (as below)
48 h after first ISO administration.
2.15. Experimental Design. Following one week of acclima-
tion, the animals were randomly divided into four groups (8
rats in each group) and were treated as follows.
Group 1 (Control). Animals were given standard laboratory
diet and water ad libitum.
Group 2 (MP). Animals were given propolis (100mg/kg) for
four weeks but were not given ISO.
Group 3 (ISO). Animals were injectedwith ISO (85mg/kg) on
the 29th and 30th days.
Group 4 (MP + ISO). Animals received MP (100mg/kg) for
4 weeks prior to ISO (85mg/kg) administration on the 29th
and 30th days.
During the experimental period, the rats’ body weights
were recorded regularly and the doses modulated accord-
ingly. Propolis dosage administered at 100mg/kg was based
on that reported in a previous study [30]. One day after the
second ISO injection, the animals were anesthetized with
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ketamine hydrochloride injection (100mg/kg) for sacrifice
prior to dissection. Blood samples (5mL)were collected from
the inferior vena cava of the rats. In addition, heart tissue
was excised immediately from the surrounding tissues and
waswashed twicewith ice-cold phosphate buffer saline (PBS),
followed by storage at −20∘C prior to analysis. Some of the
heart samples were stored in 10% formalin for histopatholog-
ical examination.
2.16. Serum Collection for Further Study. Blood samples
(3mL) were transferred to clean dry centrifuge tubes to
allow for coagulation at an ambient temperature. The serum
was separated by centrifugation at 2000 rpm for 10min.
The serum was kept at −20∘C for subsequent biochemical
analyses. The heart samples were homogenized in phosphate
buffer (25mM, pH 7.4) using a tissue homogenizer (F
12520121, Omni International, Kennesaw, USA) to make an
approximately 10% w/v homogenate. This homogenate was
centrifuged at 1700 rpm for 10min. The supernatant was
collected and stored at −20∘C for biochemical analyses.
2.17. Estimation of Cardiac Troponin I (cTn I). The heart-
specific troponin I (cTn I) level in the sera was estimated
via enzyme immunoassay kits (JAJ International Inc., USA)
using an ELISA reader (Digital and Analog System RS232,
Das, Italy).
2.18. Assay of Cardiac Marker Enzymes. The serum activities
of creatinine kinase-MB (CK-MB), aspartate transaminase
(AST), lactate dehydrogenase (LDH), and alanine transam-
inase (ALT) were estimated via commercially available stan-
dard assay kits (Stanbio Laboratory, USA) using a PD-303S
spectrophotometer (APEL, Japan).
2.19. Analyses of Lipid Profiles. The serum levels of total
cholesterol (TC), triglycerides (TGs), and high-density lipo-
protein-cholesterol (HDL-C) were estimated using commer-
cially available standard assay kits (Stanbio Laboratory, USA).
Serum VLDL-C levels were calculated by a formula provided
by Friedewald et al. [31]:
VLDL-C = TG5 . (2)
2.20. Estimation of LPO Products. Malondialdehyde (MDA)
levels were assayed for LPO products in heart tissues accord-
ing to the method described by Ohkawa et al. [32]. Briefly,
tissue homogenate (0.2mL) was mixed with 8.1% sodium
dodecyl sulfate (0.2mL), 20% acetic acid (1.5mL), and 8%
thiobarbituric acid (1.5mL). The mixture was supplemented
up to 4mL with distilled water and was heated at 95∘C in a
water bath for 60min.After incubation, the tubeswere cooled
to room temperature, and the final volume was increased to
5mL. A butanol : pyridine (15 : 1) mixture (5mL) was added,
and the contents were vortexed thoroughly for 2min. After
centrifugation at 3,000 rpm for 10min, the upper organic
layer was aspirated and its absorbance was read at 532 nm
against a blank. The levels of MDA were expressed as nmol
of thiobarbituric acid reactive substances (TBARS) per mg of
protein.
2.21. Estimation of Antioxidant Enzymes. The levels of endog-
enous antioxidant or antiperoxidative enzymes, such as
superoxide dismutase (SOD), glutathione peroxidase (GPx),
glutathione reductase (GRx), and glutathione-S-transferase
(GST), in the rats’ heart tissues were estimated using standard
assay kits (Abnova Corporation, Taiwan). To this end, the
heart tissue homogenates were recentrifuged at 12,000 rpm
for 10min at 4∘C using Eppendorf 5415D centrifuges (Ham-
burg, Germany). The resulting clean supernatants of tissue
homogenates were fed into the assays. The SOD activity
was expressed as units/mg of protein, GPx and GRx activ-
ities were expressed as nmol NADPH oxidized/min/mg of
protein, and GST activity was expressed as nmol CDNB
conjugated/min/mg of protein.
The total protein content in the recentrifuged tissue
homogenates was estimated by the method described by
Lowry et al. [27]. Briefly, 0.2mLof sample (digestedwith 0.1 N
NaOH) was mixed with 2mL of working reagent (a mixture
of 2% sodium carbonate, 0.1 NNaOH, 1.56% copper sulfate,
and 2.37% sodium-potassium tartrate), and the reaction
mixture was incubated for 10min at room temperature. The
addition of 1 N Folin-Ciocalteu’s phenol reagent (0.2mL)
was followed by 30min of incubation at room temperature.
Finally, the absorbance was measured at 660 nm using a
spectrophotometer (APEL, Japan). BSA was used as the
standard.
2.22. Histopathological Examination. The heart was rapidly
dissected out and washed immediately with saline after
sacrifice. It was then fixed in 10% formalin. The fixed tissues
were then embedded in paraffin. The tissues were sectioned
into 5 𝜇m slices using a rotary microtome and then stained
with hematoxylin and eosin dye for observation under a light
microscope (MZ3000 Micros, St Veit/Glan, Austria) at 40x
magnification. The pathologist performing the histopatho-
logical evaluation was blinded to the treatment assignment
of the different study groups.
2.23. Statistical Analysis. All analyses were conducted in
triplicate and the data are expressed as the mean ± standard
deviation (SD). The data were analyzed using GraphPad
PRISM (version 6.05; GraphPad software Inc., SanDiego, CA,
USA), Microsoft Excel 2007 (Redmond, Washington, USA),
and SPSS (Statistical Packages for Social Science, version
20.0, IBM Corporation, New York, USA). The mean values
of different groups were compared using one-way analysis of
variance (ANOVA). Statistical analyses of biochemical data
were conducted using Tukey’s test. The minimum level of
significance was set to <0.05.
3. Results
3.1. Antioxidant Constituents. The bioactive polyphenols,
flavonoids, tannin and ascorbate, protein, and reducing sugar
contents in MP are presented in Table 1.
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Table 1: Total polyphenols, flavonoids, tannins, protein, ascorbic
acid, and reducing sugar contents in MP.
Phytochemicals Amount present in propolis (mg/g)
Total polyphenols (GAEs) 15.93 ± 0.18
Total flavonoids (CEs) 1.65 ± 0.10
Total tannins (TEs) 5.81 ± 1.65
Ascorbic acid (AEs) 0.91 ± 0.02
Total protein (BSA) 24.54 ± 0.26
Reducing sugar (D-glucose) 38.22 ± 3.22
Data are presented as means ± SD.
GAE: gallic acid equivalents; CE: catechin equivalents; TE: tannic acid
equivalent; AE: ascorbate equivalent; BSA: bovine serum albumin.
%
 o
f i
nh
ib
iti
on
Ascorbic acid (standard)
Propolis
1 2 3 4 50
40
50
60
70
Concentration (𝜇g mL−1)
Figure 1: Percentage of DPPH inhibition of propolis against an
ascorbic acid standard showing a dose-dependent inhibition poten-
tial.
3.2. Antioxidant Activity Assay. The antioxidant potential
of MP was determined by both DPPH scavenging activity
and the FRAP assay. The estimated IC50 value of DPPH
scavenging activity was 1.08 𝜇g/mL (Figure 1), and the FRAP
value was 954.29 ± 3.40 [𝜇M Fe(II)]/kg.
3.3.The Effects of Propolis on Biochemical Parameters. During
the treatment period (4 weeks), no death was observed in any
of the experimental groups, and no significant difference in
bodyweight was observed between different groups (Table 2).
The heart weight increased significantly in ISO-administered
rats compared with that of normal control rats. However,
a significant reduction in heart weight was observed in the
propolis treatment (MP + ISO) group compared with that of
the rats treated with ISO alone.
Serum cTn I levels were significantly increased in ISO-
administered rats compared with those of the normal con-
trols (Figure 2). However, a significant reduction in serum
cTn I levels was observed in animals receiving prior treatment
with propolis compared with those of ISO-treated rats.
Amarked increase in serumcardiac enzyme activitieswas
observed in ISO-induced myocardial ischemic rats. Again,
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Figure 2: Effect of MP on serum cTn I in normal and treated rats.
The bars represent means ± SD (𝑛 = 8); bars with different letters
(a, b, c) indicate significantly different mean values at 𝑝 < 0.05. ND:
not detected.
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Figure 3: Effects of MP and ISO on serum CK-MB and LDH levels
in normal and different treated rats. The bars represent means ± SD
(𝑛 = 8); bars with different letters (a, b, c, d) indicate significantly
different mean values at 𝑝 < 0.05. MP: Malaysian Propolis. ISO:
isoproterenol.
pretreatment with propolis significantly decreased the levels
of CK-MB, LDH, AST, and ALT in rats challenged with ISO
(Figures 3 and 4).
A marked increase in circulating levels of TC, TGs, and
VLDL-C and a corresponding decrease in HDL-C level were
observed in ISO-treated rats (Figure 5). Again, pretreatment
with propolis was observed to significantly reduce the levels
of TC, TGs, and VLDL-C while increasing the HDL-C level
compared with the levels measured for the ISO-challenged
group.Administration ofMP alone did not significantly affect
the lipid profile compared with that of normal control group.
ISO-induced rats exhibited a significant increase inMDA
levels compared with the levels measured for the normal
control group. Propolis pretreatment, however, significantly
ameliorated the increase (Figure 6).
Table 3 presents the effects of propolis on the activities
of antioxidant enzymes such as SOD, GRx, GPx, and GST in
the heart tissue. Rats induced with ISO exhibited a significant
decrease in the level of antioxidant enzymes compared with
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Table 2: Effect of MP on body weights (BW) and absolute and relative heart weights.
Parameters Treatment
Control MP ISO MP + ISO
Initial BW (g) 133.25 ± 9.66a 148.62 ± 10.07a 139.75 ± 13.76a 135.12 ± 7.86a
Final BW (g) 162.37 ± 4.62a 176.25 ± 16.61a 169.25 ± 16.61a 167.87 ± 7.69a
BW gain (%) 17.98 ± 4.49a 16.76 ± 2.32a 17.39 ± 2.28a 19.54 ± 1.24a
Absolute heart weight (g) 0.67 ± 0.08a 0.68 ± 0.04a 0.92 ± 0.05c 0.75 ± 0.02b
Relative heart weight (g/100 g) 0.41 ± 0.05a 0.41 ± 0.02a 0.54 ± 0.02b 0.45 ± 0.02a
Data are presented as means ± SD, 𝑛 = 8.
a,b,cValues in the same row that do not share superscript letters (a, b, and c) differ significantly at 𝑝 < 0.05;% of body weight (BW) gain = [(final BW − initial
BW)/ final BW] × 100.
MP: Malaysian Propolis. ISO: Isoproterenol.
Table 3: Effects of MP and ISO on the activities of superoxide dismutase (SOD), glutathione reductase (GRx), glutathione peroxidase (GPx),
and glutathione-S-transferase (GST) in the heart tissue of normal and treated rats.
Parameters Treatment
Control MP ISO MP + ISO
SOD (units/mg of protein) 1.53 ± 0.15a 1.96 ± 0.04a 0.13 ± 0.02c 0.31 ± 0.05b
GRx (nmol NADPH oxidized/min/mg of protein) 96.23 ± 6.70a 94.32 ± 1.74a 71.07 ± 4.78b 89.13 ± 9.28a
GPx (nmol NADPH oxidized/min/mg of protein) 2.95 ± 0.57a 2.27 ± 0.52a 0.90 ± 0.02b 1.98 ± 0.51a
GST (nmol CDNB conjugated/min/mg of protein) 2.08 ± 0.20a 2.55 ± 0.43a 1.29 ± 0.18b 2.13 ± 0.63a
Data are presented as means ± SD, 𝑛 = 8.
a,b,cValues in the same row that do not share superscript letters (a, b, and c) indicate significant difference at 𝑝 < 0.05.
MP: Malaysian Propolis. ISO: isoproterenol.
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Figure 4: Effects of MP and ISO on serum AST and ALT levels in
normal and different treated rats. The bars represent means ± SD
(𝑛 = 8); bars with different letters (a, b, c) indicate significantly
different mean values at 𝑝 < 0.05. MP: Malaysian Propolis. ISO:
isoproterenol.
the level measured for the control group. However, pretreat-
ment with propolis significantly ameliorated the levels of
SOD, GRx, GPx, and GST enzymes compared with the levels
measured for the rats treated with ISO alone.
Normal cardiac muscle fibers without any infarction
were observed in normal control rats (Figure 7(a)). Rats
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Figure 5: Effects of MP and ISO on serum lipid profile in
normal and different treated rats. The bars represent means ± SD
(𝑛 = 8); bars with different letters (a, b, c) indicate significantly
different mean values at 𝑝 < 0.05. MP: Malaysian Propolis. ISO:
isoproterenol.
treated with propolis alone also showed normal cardiac
muscle bundles without any infarction or tissue damage
(Figure 7(b)). ISO-treated rats showed myocardial structural
changes, including coagulative necrosis, separation of cardiac
muscle fibers, and infiltration of inflammatory cells (Fig-
ure 7(c)). Pretreatment with propolis decreased the degree of
infiltration of inflammatory cells (Figure 7(d)).
Histological changes in the heart in the various groups are
presented in Table 4.
Evidence-Based Complementary and Alternative Medicine 7
Control MP ISOMP + ISO
a a
b
c
0
10
20
30
40
50
60
70
80
90
100
TB
A
RS
 (n
m
ol
/m
g 
of
 p
ro
te
in
)
Figure 6: Effects of MP and ISO on cardiac LPO levels in normal
and different treated rats. The bars represent means ± SD (𝑛 = 8);
bars with different letters (a, b, c) indicate significantly different
mean values at 𝑝 < 0.05.
Table 4: Semiquantitative scoring of the architectural changes evi-
denced by histopathological examination of rat myocardial tissues.
Parameters Treatment
Control MP ISO MP + ISO
Muscle separation − − +++ +
Cellular necrosis − − +++ +
Inflammatory cells infiltration − − +++ +
Edematous intramuscular space − − +++ ++
Scoring was performed as follows: none (−), mild (+), moderate (++), and
severe (+++).
4. Discussion
To the best of our knowledge, our study is the first to deter-
mine the antioxidant potentials ofMalaysian bee propolis and
to investigate the effects of a propolis extract on myocardial
ischemia based on the findings of several biochemical mark-
ers in addition to histopathological findings in a rat model.
Polyphenols and flavonoids are important constituents
that contribute to the functional quality, color, and flavor of
bee products and serve as powerful antioxidants due to the
hydrogen-donating ability of their hydroxyl groups as well
as their ability to donate electrons to arrest the production
of free radicals as a result of oxidative stress [33]. Tannins
are another important subclass of water-soluble phenolic
compounds. They have been reported to exhibit significant
astringent, antimicrobial, and antioxidant properties [34, 35].
Our findings indicate that MP serves as a reserve source of
phenolics, flavonoids, and tannins and may therefore play a
significant role as a singlet oxygen quencher and free radical
scavenger to minimize molecular damage of the cell.
Ascorbic acid is a small antioxidantmolecule that directly
interacts with a broad spectrum of ROS, terminating the
chain reaction initiated by free radicals via electron transfer as
well as participating in the regeneration of vitamin E [33]. To
the best of our knowledge, our study is the first to report on
the ascorbic acid content of MP, which, when coupled with
the presence of other antioxidants, can be used as a natural
source of antioxidants. Our study also confirms that MP is a
rich source of reducing sugars with a significant amount of
protein.
The antioxidant activities of MP were evaluated by FRAP
and DPPH assays. FRAP assays primarily measure the abil-
ities of antioxidants to reduce ferric tripyridyltriazine (Fe3+)
to their ferrous form (Fe2+), whereas DPPH assays measure
percentages of radical-scavenging activity [35]. The FRAP
and DPPH assays confirmed the high antioxidant potential
of MP, as previously reported [9].
MI is a clinical syndrome arising from sudden and
persistent curtailment of myocardial blood supply, resulting
in the necrosis of myocardium [36]. Administration of
ISO contributes to the release of cellular enzymes in the
circulation due to irreversible cardiac damage, which leads
to an alteration in the integrity of the plasma membrane
as a response to 𝛽-adrenergic stimulation. The stimulation
generates ROS and downregulates copper-zinc superoxide
dismutase activity, reduces glutathione levels (which leads
to the loss of membrane integrity), induces heart contrac-
tile dysfunction and myocyte toxicity, and finally produces
myocardial necrosis [37]. In the present study, the heart
weights increased significantly with relatively no change
in body weight following ISO administration, which con-
tributed to the increased heart weight to body weight ratio.
The increased heart weights may be attributed to increased
water content and edematous intramuscular space [38],
which was confirmed by our histopathological findings. Pre-
treatment with propolis, however, helped to maintain near-
normal heart weights, indicating the therapeutic benefits of
the substance.
Cardiac troponin I (cTn I) is a contractile protein that is a
highly sensitive and specificmarker of myocardial cell injury;
it is normally absent in serum and released only following
myocardial necrosis [39]. Our study confirmed that serum
cTn I levels were significantly higher in ISO-treated rats
than in the normal control group, which may be attributed
to ISO-induced cardiac damage. The results are consistent
with those reported by Afroz et al. [12]. Animals challenged
with ISO after pretreatment with propolis, however, showed
significantly lower cTn I levels compared with those of rats
treated with ISO alone. This phenomenon may be attributed
to the protective effect of phenolics in propolis on the
myocardium by preserving the structural and functional
integrity of the contractile apparatus and thus preventing
oxidative injury of cardiac muscles.
An insufficient supply of oxygen or nutrients to cardiac
tissues or chemically induced cardiac damage may increase
the permeability or even rupture the cardiac membrane,
resulting in leakage of cytosolic enzymes, including CK-
MB, AST, LDH, and ALT (diagnostic markers of MI), into
the bloodstream and a subsequent increase in their serum
concentrations [12, 40]. The CK-MB activity assay is an
important and reliable diagnostic index for MI because of
the marked abundance of CK-MB in the myocardium and
its virtual absence in most other tissues and consequent
sensitivity [41]. In the present study, ISO administration
in rats caused a marked elevation in the activities of all
the cardiac marker enzymes in the serum, in accord with
previously reported studies [12, 18], an important indication
of ISO-induced necrotic damage of the myocardium and
leakiness of the plasma membrane. Pretreatment with MP,
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Figure 7: (a) Group I: H & E stained myocardial tissue section from normal control heart showing normal cardiac muscle fibers. (b) Group
II: pretreatment with MP (100mg/kg) showing normal muscle fibers without any pathological changes. (c) Group III: ISO (85mg/kg) treated
heart showing cardiac muscle fibers with muscle separation (black arrows), edematous intramuscular space (red arrows), cellular necrosis
(blue arrows), and infiltration of inflammatory cells (green arrows). (d) MP (100mg/kg) + ISO (85mg/kg) treated heart showing lowered
inflammatory cells (green arrows) and reduced muscle fibrous separation with edematous intramuscular space.
however, significantly ameliorated the activities of all marker
enzymes in the serum, indicating that propolis helpsmaintain
membrane integrity, thereby limiting the leakage of the
enzymes. Polyphenols such as tannic acid, ascorbic acid,
flavonoids, and reducing sugars confirmed to be present in
MP are important constitutive antioxidants that may confer a
protective effect against oxidative cardiac injury, thus restrict-
ing the leakage of these enzymes from the myocardium.
Plasma cholesterols and triglycerides play a key role
in the pathogenesis of cardiovascular disease not only due
to the development of atherosclerosis but also due to the
modification of the composition, structure, and stability of
cellularmembranes [42]. A significant increase in the levels of
TC, TG, and VLDL-C along with a decrease in HDL-C levels
was observed in ISO-treated rats, as previously reported [40].
There are a positive correlation between high levels of LDL-
C and VLDL-C with MI and a negative correlation between
high levels of HDL-C and MI. HDL-C inhibits the uptake
of LDL-C by the arterial walls and facilitates the transport
of cholesterol from peripheral tissues to the liver and is
catabolized and excreted from the body [43]. Administration
of MP significantly restored these alterations, thereby main-
taining the normal fluidity and function of the myocardial
membrane. The improvement in lipoprotein status has been
due to the polyphenols in MP, which are responsible for the
upregulation of proinflammatory cytokines, chemokines, and
angiogenic factors and consequent inhibition of progression
of atherosclerosis [44].
Propolis is also reported to downregulate the mRNA
expression of key genes, including monocyte chemoattrac-
tant protein (MCP)-1, interferon gamma, interleukin-6, clus-
ter of differentiation (CD) 36, and transforming growth
factor beta (TGF-𝛽), which have been associated with the
atherosclerotic process [44, 45]. Moreover, MP lowered
TC levels and elevated HDL-C levels, as also reported by
Daleprane et al. [45], which may contribute to the upregu-
lation of ABCA 1 gene expression associated with increased
HDL-C levels and restoration of lipid profiles in animals [44].
LPO, a type of oxidative deterioration of PUFAs, has been
linked to pathogenic events in MI [14, 40]. The myocardial
necrosis observed in the rats receiving ISO can be attributed
to peroxidative damage because it has been previously
reported that ISO generates lipid peroxides [46]. Increased
LPO appears to be the initial stage of the pathogenesis, mak-
ing heart tissue more susceptible to oxidative damage [18].
ISO administration caused amarked elevation in LPO, which
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was expressed as MDA content, in line with previous reports
[14, 40]. Oral pretreatment withMP led to a significant reduc-
tion inmyocardialMDAcontent.This result can be attributed
to the presence of flavonoids in MP, which can scavenge
LPO products generated excessively by ISO, thus conferring
protection to the cardiac tissue [47]. It has been reported that
the synergistic scavenging effects of bee products may be due
to both enzymatic and nonenzymatic antioxidants involved
in cardiovascular defense mechanisms [48, 49].
The oxidative stress may be exerted through quinone
metabolites of ISO that react with molecular oxygen to
produce superoxide anions and other ROS, which may
interfere with cellular antioxidant enzymes [18]. Endogenous
antioxidant enzymatic defense plays a key role in neutral-
izing oxygen free radical-mediated tissue injury [50]. SOD,
catalase, and GPx are the primary free radical-scavenging
enzymes involved in the first line of cellular defense against
oxidative injury, removing both oxygen (O2) and hydrogen
peroxide (H2O2) before they can interact to form more
reactive hydroxyl radicals [51, 52].
In our study, significantly reduced activities of SOD and
GPx and GRx and GST were observed in the heart tissues
of ISO-treated rats compared with the activities observed in
control rats. The observed decreases in the activities of these
enzymes are in accord with findings reported in previous
studies [12, 53]; such decreases may be due to the increased
utilization of these enzymes for scavenging ROS and their
inactivation by excessive ISO oxidants [52]. Pretreatment
with MP, however, improved the activities of cellular antiper-
oxidative enzymes. The findings could be due to the direct
free radical-scavenging potency of phenolics in propolis [47].
It is also plausible that MP restores antioxidant enzyme
function via upregulation of the activity or expression ofNrf2,
an important intracellular transcription factor, released from
its repressor (Keap1) under oxidative or xenobiotic stress [46].
The released Nrf2 binds to the antioxidant response element
(ARE) in the promoter region of cytoprotective genes and
induces their expression.The transcribed genes subsequently
induce the expression of free radical-scavenging enzymes
to neutralize, detoxify, and eliminate the cytotoxic oxidants
[46, 54, 55].
The biochemical improvements reported in the current
study are consistent with the histopathological findings, in
which the heart tissues of normal control rats and rats
treated with MP alone clearly illustrated the integrity of
the myocardial cell membrane. The tissue of rats treated
with ISO alone showed widespread myofibrillar disorder,
necrosis of myocytes, inflammatory cell infiltration, and
cardiac muscle fiber separation. However, MP-pretreated
hearts showed a near-normal morphology of cardiac muscle
with the absence of necrosis and reduced inflammatory cells
compared with the hearts of rats treated with ISO alone. Sim-
ilar histopathological findings were obtained in ISO-treated
rats with respect to gallic acid, a phenolic acid also present
in honey [56], which also showed remarkable antioxidant
properties, further supporting the antioxidant potential of
MPas a cardioprotectant.Nevertheless, further researchmust
be undertaken to investigate the active constituents present in
MP to confirm the cardioprotective mechanism.
5. Conclusion
MP is a promising source of natural antioxidants, as con-
firmed by its high polyphenols, flavonoids, tannins, ascorbic
acid, and reducing sugar contents, as well as its considerably
high DPPH free radical-scavenging activities and FRAP
values. Our in vivo study confirmed that MP significantly
altered nearly all biochemical parameters associated with
ISO-induced myocardial injury, as further supported by
histopathological findings. MP may have antilipoperoxida-
tive and antioxidant effects that confer these cardioprotective
effects.
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